Doxorubicin for treatment of canine lymphosarcoma after development of resistance to combination chemotherapy.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004317:Doxorubicin / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination / Q000662:veterinary; D005260:Female; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000662:veterinary*; D008297:Male
D000970:Antineoplastic Agents; D004317:Doxorubicin